… interferon-α therapy could protect against relapse and improve survival of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation …

MZ Shen, XH Zhang, LP Xu, Y Wang, CH Yan… - Frontiers in …, 2022 - frontiersin.org
… , and a positive result of bone marrow specimen examined by … New molecular markers with
higher sensitivity and specificity … now (59), and future studies can further assess the efficacy of …

[HTML][HTML] … for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study

XD Mo, XH Zhang, LP Xu, Y Wang, CH Yan… - … Marrow Transplantation, 2017 - Elsevier
… This study had several limitations. First, this is a single-center study, and a future
multicenter study may further confirm the efficacy of MRD-directed IFN-α treatment after allo-HSCT. …

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

H Jiang, XH Liu, J Kong, J Wang, JS Jia… - Leukemia & …, 2021 - Taylor & Francis
bone marrow is referred to in the literature [Citation23]. The method of analysis of bone marrow
… Palva et al. conducted a prospective controlled multicenter trial to determine the value of …

… Residual Disease in Patients with t (8; 21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study

XD Mo, Y Wang, XH Zhang, LP Xu, CH Yan… - The …, 2018 - academic.oup.com
prospective multicenter study demonstrated that allogeneic hematopoietic stem cell
transplantationBone marrow samples were collected as part of the treatment protocol. Routine …

Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT

S Liu, X Luo, X Zhang, L Xu, Y Wang, C Yan, H Chen… - Scientific Reports, 2020 - nature.com
… was further supported by a large scale study recently 25 . IFN-α can … Our future prospective
studies can further compare the … fresh, and unmanipulated bone marrow cells plus peripheral …

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis

S Fan, TZ Pan, LP Dou, YM Zhao, XH Zhang… - Frontiers in …, 2023 - frontiersin.org
… cell transplantation (allo-HSCT). Therefore, this study aimed to further assess its efficacy in
a multicenter … These results should be further confirmed in a prospective study with a larger …

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

AS Henden, A Varelias, J Leach, E Sturgeon… - Blood …, 2019 - ashpublications.org
studied in a larger, multicenterinterferon-α monotherapy in acute leukemia patients with
relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study

A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation

ED Bezerra, ME Flowers, LE Onstad… - Leukemia & …, 2019 - Taylor & Francis
… of Philadelphia (Ph) chromosome in the bone marrow (BM) by conventional cytogenetics. …
of the power of the immune system and new immune modulation therapies are emerging to …

… response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German study group-myeloproliferative neoplasms …

F Stegelmann, LL Teichmann, FH Heidel, CC Crodel… - Leukemia, 2023 - nature.com
… (IFN) may also prevent disease progression to SMF, as recently … ET was diagnosed after
bone marrow biopsy in all cases … Prospective studies assessing JAK2 allele burden monitoring …

Recombinant interferon-β in the treatment of polycythemia vera and related neoplasms: rationales and perspectives

H Hasselbalch, V Skov, L Kjær, MK Larsen… - Cancers, 2022 - mdpi.com
… are described, and future research directions are outlined for … was not a candidate for bone
marrow transplantation. Thus, … Based on the above data, a multicenter trial of tamoxifen was …